vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and American Express (AXP). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $18.9M, roughly 1.0× American Express). American Express runs the higher net margin — 15.7% vs -6.8%, a 22.5% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 11.4%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -95.6%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products an...
APYX vs AXP — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $18.9M |
| Net Profit | $-1.3M | $3.0M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | — |
| Net Margin | -6.8% | 15.7% |
| Revenue YoY | 34.7% | 11.4% |
| Net Profit YoY | 71.9% | 15.0% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $18.9M | ||
| Q4 25 | $19.2M | $10.9B | ||
| Q3 25 | $12.9M | $10.4B | ||
| Q2 25 | $11.4M | $10.3B | ||
| Q1 25 | $9.4M | $9.6B | ||
| Q4 24 | $14.2M | $10.0B | ||
| Q3 24 | $11.5M | $9.7B | ||
| Q2 24 | $12.1M | $9.8B |
| Q1 26 | — | $3.0M | ||
| Q4 25 | $-1.3M | $2.5B | ||
| Q3 25 | $-2.0M | $2.9B | ||
| Q2 25 | $-3.8M | $2.9B | ||
| Q1 25 | $-4.2M | $2.6B | ||
| Q4 24 | $-4.6M | $2.2B | ||
| Q3 24 | $-4.7M | $2.5B | ||
| Q2 24 | $-6.6M | $3.0B |
| Q1 26 | — | — | ||
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 28.2% | ||
| Q3 25 | -6.5% | 36.7% | ||
| Q2 25 | -22.6% | 34.4% | ||
| Q1 25 | -32.4% | 34.6% | ||
| Q4 24 | -21.4% | 27.7% | ||
| Q3 24 | -31.6% | 33.0% | ||
| Q2 24 | -45.7% | 38.6% |
| Q1 26 | — | 15.7% | ||
| Q4 25 | -6.8% | 22.5% | ||
| Q3 25 | -15.4% | 27.9% | ||
| Q2 25 | -33.2% | 28.0% | ||
| Q1 25 | -44.0% | 26.8% | ||
| Q4 24 | -32.5% | 21.8% | ||
| Q3 24 | -40.9% | 25.8% | ||
| Q2 24 | -54.0% | 30.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.52 | ||
| Q3 25 | — | $4.14 | ||
| Q2 25 | — | $4.08 | ||
| Q1 25 | — | $3.64 | ||
| Q4 24 | — | $3.04 | ||
| Q3 24 | — | $3.49 | ||
| Q2 24 | $-0.19 | $4.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | — |
| Total DebtLower is stronger | $37.5M | $60.4M |
| Stockholders' EquityBook value | $14.5M | $34.0M |
| Total Assets | $66.8M | $308.9M |
| Debt / EquityLower = less leverage | 2.58× | 1.78× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $31.7M | $742.0M | ||
| Q3 25 | $25.1M | $1.3B | ||
| Q2 25 | $29.3M | $197.0M | ||
| Q1 25 | $31.0M | $261.0M | ||
| Q4 24 | $31.7M | $221.0M | ||
| Q3 24 | $28.0M | $120.0M | ||
| Q2 24 | $32.7M | $188.0M |
| Q1 26 | — | $60.4M | ||
| Q4 25 | $37.5M | $56.4B | ||
| Q3 25 | $37.5M | $57.8B | ||
| Q2 25 | $37.5M | $58.2B | ||
| Q1 25 | $37.5M | $51.2B | ||
| Q4 24 | $37.5M | $49.7B | ||
| Q3 24 | $37.5M | $53.5B | ||
| Q2 24 | — | $51.5B |
| Q1 26 | — | $34.0M | ||
| Q4 25 | $14.5M | $33.5B | ||
| Q3 25 | $5.8M | $32.4B | ||
| Q2 25 | $7.3M | $32.3B | ||
| Q1 25 | $10.5M | $31.2B | ||
| Q4 24 | $14.2M | $30.3B | ||
| Q3 24 | $11.0M | $29.7B | ||
| Q2 24 | $14.7M | $29.5B |
| Q1 26 | — | $308.9M | ||
| Q4 25 | $66.8M | $300.1B | ||
| Q3 25 | $57.4M | $297.6B | ||
| Q2 25 | $58.2M | $295.6B | ||
| Q1 25 | $60.2M | $282.2B | ||
| Q4 24 | $64.8M | $271.5B | ||
| Q3 24 | $60.7M | $271.0B | ||
| Q2 24 | $65.4M | $272.2B |
| Q1 26 | — | 1.78× | ||
| Q4 25 | 2.58× | 1.68× | ||
| Q3 25 | 6.41× | 1.78× | ||
| Q2 25 | 5.17× | 1.80× | ||
| Q1 25 | 3.57× | 1.64× | ||
| Q4 24 | 2.64× | 1.64× | ||
| Q3 24 | 3.40× | 1.80× | ||
| Q2 24 | — | 1.74× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | — |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -14.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.5M | $3.1B | ||
| Q3 25 | $-3.5M | $6.2B | ||
| Q2 25 | $-1.2M | $4.4B | ||
| Q1 25 | $-702.0K | $4.8B | ||
| Q4 24 | $-2.9M | $5.8B | ||
| Q3 24 | $-4.4M | $-1.8B | ||
| Q2 24 | $-4.3M | $4.5B |
| Q1 26 | — | — | ||
| Q4 25 | $-2.8M | $2.3B | ||
| Q3 25 | $-4.1M | $5.6B | ||
| Q2 25 | $-1.5M | $3.7B | ||
| Q1 25 | $-757.0K | $4.3B | ||
| Q4 24 | $-3.2M | $5.3B | ||
| Q3 24 | $-4.6M | $-2.3B | ||
| Q2 24 | $-4.6M | $4.0B |
| Q1 26 | — | — | ||
| Q4 25 | -14.6% | 21.4% | ||
| Q3 25 | -31.5% | 53.6% | ||
| Q2 25 | -13.2% | 36.3% | ||
| Q1 25 | -8.0% | 45.0% | ||
| Q4 24 | -22.4% | 53.1% | ||
| Q3 24 | -40.0% | -23.3% | ||
| Q2 24 | -38.0% | 40.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | 6.6% | ||
| Q3 25 | 4.0% | 6.3% | ||
| Q2 25 | 2.3% | 6.0% | ||
| Q1 25 | 0.6% | 4.5% | ||
| Q4 24 | 1.7% | 5.0% | ||
| Q3 24 | 1.3% | 4.7% | ||
| Q2 24 | 2.4% | 5.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.25× | ||
| Q3 25 | — | 2.15× | ||
| Q2 25 | — | 1.51× | ||
| Q1 25 | — | 1.84× | ||
| Q4 24 | — | 2.66× | ||
| Q3 24 | — | -0.72× | ||
| Q2 24 | — | 1.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APYX
Segment breakdown not available.
AXP
| Discount revenue | $9.5M | 50% |
| Other | $8.9M | 47% |
| Deposits with banks and other | $512.0K | 3% |
